STOCK TITAN

[S-8 POS] Streamline Health Solutions, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8 POS
Rhea-AI Filing Summary

Streamline Health Solutions, Inc. submitted post-effective amendments removing unsold securities from multiple Form S-8 registration statements after completing a merger that made the company a wholly owned subsidiary of its buyer. The amendments cover several prior S-8 filings that collectively reserved millions of shares for employee plans, including a 2024 registration for 6,738,902 shares and earlier registrations ranging from 75,000 to 2,000,000 shares. The filing notes that those registered amounts do not reflect a 1-for-15 reverse stock split previously effected. In accordance with its registration undertakings, the registrant withdraws from registration any shares that remained unsold at the termination of its offerings.

Streamline Health Solutions, Inc. ha presentato emendamenti post-effettivi che rimuovono i titoli invenduti da più registrazioni sul Modulo S-8 dopo aver completato una fusione che ha reso la società una sussidiaria interamente controllata dall'acquirente. Gli emendamenti riguardano diverse precedenti dichiarazioni S-8 che complessivamente riservavano milioni di azioni per piani dei dipendenti, compresa una registrazione del 2024 per 6,738,902 azioni e registrazioni precedenti da 75,000 a 2,000,000 azioni. Il deposito osserva che tali importi registrati non riflettono un 1-for-15 reverse stock split precedentemente effettuato. In conformità ai suoi impegni di registrazione, il registrante ritira dalla registrazione le azioni che erano rimaste invendute alla chiusura delle sue offerte.

Streamline Health Solutions, Inc. presentó enmiendas posteriores a la eficacia para eliminar valores no vendidos de varias declaraciones de registro del Formulario S-8 tras completar una fusión que convirtió a la compañía en una subsidiaria de propiedad total de su comprador. Las enmiendas abarcan varios registros S-8 previos que en conjunto reservaban millones de acciones para planes de empleados, incluida una inscripción de 2024 por 6,738,902 acciones y registros anteriores que iban de 75,000 a 2,000,000 acciones. El expediente indica que esos importes registrados no reflejan un 1-for-15 reverse stock split realizado anteriormente. Conforme a sus compromisos de registro, el registrante retira de la inscripción las acciones que permanecieron sin vender al término de sus ofertas.

Streamline Health Solutions, Inc.는 인수자에 의해 완전 자회사가 되는 합병을 완료한 후, 여러 Form S-8 등록명세서에서 미판매 유가증권을 제거하는 효력발생후 수정서(post-effective amendments)를 제출했습니다. 이 수정서는 직원 플랜을 위해 총수백만 주를 예약한 여러 이전 S-8 제출을 포함하며, 그중 2024년 등록은 6,738,902주, 이전 등록들은 75,000주에서 2,000,000주 사이입니다. 제출서류는 이러한 등록 수량이 이전에 시행된 1-for-15 reverse stock split을 반영하지 않는다고 밝혔습니다. 등록 약정에 따라, 등록인은 공모 종료 시점에 미판매로 남아 있던 주식을 등록에서 철회합니다.

Streamline Health Solutions, Inc. a déposé des amendements post-efficacité visant à retirer des titres invendus de plusieurs déclarations d'enregistrement Form S-8 après avoir finalisé une fusion qui a fait de la société une filiale détenue à 100 % par son acquéreur. Les amendements couvrent plusieurs dépôts S-8 antérieurs qui réservaient collectivement des millions d'actions pour des plans d'employés, y compris un enregistrement de 2024 pour 6,738,902 actions et des enregistrements antérieurs allant de 75,000 à 2,000,000 actions. Le dossier indique que ces montants enregistrés ne tiennent pas compte d'un 1-for-15 reverse stock split précédemment effectué. Conformément à ses engagements d'enregistrement, le déclarant retire de l'enregistrement les actions qui étaient restées invendues à la clôture de ses offres.

Streamline Health Solutions, Inc. hat nach dem Abschluss einer Fusion, durch die das Unternehmen zur vollständig im Eigentum seines Käufers stehenden Tochtergesellschaft wurde, nachträgliche Wirksamkeitsänderungen (post-effective amendments) eingereicht, um unveräußerte Wertpapiere aus mehreren Form S-8-Registrierungserklärungen zu entfernen. Die Änderungen betreffen mehrere frühere S-8-Anmeldungen, die zusammen Millionen von Aktien für Mitarbeiterpläne reservierten, darunter eine Registrierung aus 2024 für 6,738,902 Aktien und frühere Registrierungen im Bereich von 75,000 bis 2,000,000 Aktien. Die Einreichung weist darauf hin, dass diese registrierten Beträge einen zuvor vorgenommenen 1-for-15 reverse stock split nicht berücksichtigen. In Übereinstimmung mit ihren Registrierungspflichten zieht der Registrant die Aktien, die beim Abschluss seiner Angebote unverkauft geblieben waren, von der Registrierung zurück.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Merger closed; Streamline became a wholly owned subsidiary and its remaining employee-share registrations were formally withdrawn.

The Merger described in the filing resulted in Streamline becoming a wholly owned subsidiary of Parent, triggering routine post-closing housekeeping: post-effective amendments to Form S-8 to remove unsold registered shares. This is a procedural, contract-driven step to comply with prior registration undertakings and to align the registrants public registration status with its new corporate structure. The action itself is not an operating-change disclosure but is material as it alters the availability of registered equity for issuance under prior plans.

TL;DR: The company fulfilled its undertaking by deregistering unsold S-8 securities following change-of-control, impacting the registrants capacity to issue equity under those filings.

With the registrant now a subsidiary, removing unsold securities from public registration is a standard compliance measure. The filing specifically identifies multiple historical S-8 registrations, including a 2024 registration covering 6,738,902 shares, and confirms amounts are not adjusted for a prior 1-for-15 reverse split. For employees and plan participants, the administrative change affects which entity holds registered issuance capacity and may require future re-registration or alternative grant arrangements.

Streamline Health Solutions, Inc. ha presentato emendamenti post-effettivi che rimuovono i titoli invenduti da più registrazioni sul Modulo S-8 dopo aver completato una fusione che ha reso la società una sussidiaria interamente controllata dall'acquirente. Gli emendamenti riguardano diverse precedenti dichiarazioni S-8 che complessivamente riservavano milioni di azioni per piani dei dipendenti, compresa una registrazione del 2024 per 6,738,902 azioni e registrazioni precedenti da 75,000 a 2,000,000 azioni. Il deposito osserva che tali importi registrati non riflettono un 1-for-15 reverse stock split precedentemente effettuato. In conformità ai suoi impegni di registrazione, il registrante ritira dalla registrazione le azioni che erano rimaste invendute alla chiusura delle sue offerte.

Streamline Health Solutions, Inc. presentó enmiendas posteriores a la eficacia para eliminar valores no vendidos de varias declaraciones de registro del Formulario S-8 tras completar una fusión que convirtió a la compañía en una subsidiaria de propiedad total de su comprador. Las enmiendas abarcan varios registros S-8 previos que en conjunto reservaban millones de acciones para planes de empleados, incluida una inscripción de 2024 por 6,738,902 acciones y registros anteriores que iban de 75,000 a 2,000,000 acciones. El expediente indica que esos importes registrados no reflejan un 1-for-15 reverse stock split realizado anteriormente. Conforme a sus compromisos de registro, el registrante retira de la inscripción las acciones que permanecieron sin vender al término de sus ofertas.

Streamline Health Solutions, Inc.는 인수자에 의해 완전 자회사가 되는 합병을 완료한 후, 여러 Form S-8 등록명세서에서 미판매 유가증권을 제거하는 효력발생후 수정서(post-effective amendments)를 제출했습니다. 이 수정서는 직원 플랜을 위해 총수백만 주를 예약한 여러 이전 S-8 제출을 포함하며, 그중 2024년 등록은 6,738,902주, 이전 등록들은 75,000주에서 2,000,000주 사이입니다. 제출서류는 이러한 등록 수량이 이전에 시행된 1-for-15 reverse stock split을 반영하지 않는다고 밝혔습니다. 등록 약정에 따라, 등록인은 공모 종료 시점에 미판매로 남아 있던 주식을 등록에서 철회합니다.

Streamline Health Solutions, Inc. a déposé des amendements post-efficacité visant à retirer des titres invendus de plusieurs déclarations d'enregistrement Form S-8 après avoir finalisé une fusion qui a fait de la société une filiale détenue à 100 % par son acquéreur. Les amendements couvrent plusieurs dépôts S-8 antérieurs qui réservaient collectivement des millions d'actions pour des plans d'employés, y compris un enregistrement de 2024 pour 6,738,902 actions et des enregistrements antérieurs allant de 75,000 à 2,000,000 actions. Le dossier indique que ces montants enregistrés ne tiennent pas compte d'un 1-for-15 reverse stock split précédemment effectué. Conformément à ses engagements d'enregistrement, le déclarant retire de l'enregistrement les actions qui étaient restées invendues à la clôture de ses offres.

Streamline Health Solutions, Inc. hat nach dem Abschluss einer Fusion, durch die das Unternehmen zur vollständig im Eigentum seines Käufers stehenden Tochtergesellschaft wurde, nachträgliche Wirksamkeitsänderungen (post-effective amendments) eingereicht, um unveräußerte Wertpapiere aus mehreren Form S-8-Registrierungserklärungen zu entfernen. Die Änderungen betreffen mehrere frühere S-8-Anmeldungen, die zusammen Millionen von Aktien für Mitarbeiterpläne reservierten, darunter eine Registrierung aus 2024 für 6,738,902 Aktien und frühere Registrierungen im Bereich von 75,000 bis 2,000,000 Aktien. Die Einreichung weist darauf hin, dass diese registrierten Beträge einen zuvor vorgenommenen 1-for-15 reverse stock split nicht berücksichtigen. In Übereinstimmung mit ihren Registrierungspflichten zieht der Registrant die Aktien, die beim Abschluss seiner Angebote unverkauft geblieben waren, von der Registrierung zurück.

As filed with the Securities and Exchange Commission on August 14, 2025

 

Registration No. 333-280444

Registration No. 333-188764

Registration No. 333-208752

Registration No. 333-220953

Registration No. 333-233728

Registration No. 333-258445

Registration No. 333-265774

Registration No. 333-272995

 



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-280444

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-188764

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-208752

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-220953

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-233728

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-258445

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-265774

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-272995

 

UNDER

THE SECURITIES ACT OF 1933

 


 

STREAMLINE HEALTH SOLUTIONS, INC.

(Exact Name of Registrant as Specified in its Charter)

 


 

Delaware

 

0-28132

 

31-1455414

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission File Number)

 

(I.R.S. Employer

Identification No.)

         

2400 Old Milton Pkwy., Box 1353

Alpharetta, GA 30009

(203) 883-9490

(Address of Principal Executive Offices) (Zip Code)

 

Streamline Health Solutions, Inc. 2025 Omnibus Incentive Compensation Plan
Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan

(Full title of the plans)

 

 

Bryant J. Reeves, III

 

Chief Financial Officer

2400 Old Milton Pkwy., Box 1353

Alpharetta, Georgia 30009

(888) 997-8732

 

(Name and address of agent for service) (Telephone number, including area code, of agent for service)

 

 

 

 

Copies to:

David W. Ghegan

Cody M. Mathis

Troutman Pepper Locke LLP

600 Peachtree Street NE, Suite 3000

Atlanta, Georgia 30308

(404) 885-3139

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

               

Large accelerated filer

 

 

Accelerated filer

     
         

Non-accelerated filer

 

x

 

Smaller reporting company

 

x

 
         
       

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 



 

 


 

 

 

EXPLANATORY NOTE DEREGISTRATION OF SECURITIES

 

These Post-Effective Amendments (these “Post-Effective Amendments”) relate to the following Registration Statements on Form S-8 (each, a “Registration Statement,” and collectively, the “Registration Statements”), filed with the Securities and Exchange Commission (the “SEC”) by Streamline Health Solutions, Inc., a Delaware corporation (the “Registrant”):

 

 

Registration Statement on Form S-8 (No. 333‑188764), filed with the SEC on May 22, 2013, pertaining to the registration of 2,000,000 shares of common stock, par value $0.01 per share (“Common Stock”) of the Registrant reserved for issuance under the Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan (the “2013 Plan”);

 

 

Registration Statement on Form S-8 (No. 333‑208752), filed with the SEC on December 24, 2015, pertaining to the registration of (i) an additional 1,600,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 300,000 shares of Common Stock issuable upon the exercise of new employee inducement stock option awards;

 

 

Registration Statement on Form S-8 (No. 333‑220953), filed with the SEC on October 13, 2017, pertaining to the registration of (i) an additional 300,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 75,000 shares of Common Stock issuable upon the exercise of a new employee inducement stock option award;

 

 

Registration Statement on Form S-8 (No. 333‑233728), filed with the SEC on September 12, 2019, pertaining to the registration of (i) an additional 1,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 225,000 shares of Common Stock issuable under new-employee inducement restricted stock awards;

 

 

Registration Statement on Form S-8 (No. 333‑258445), filed with the SEC on August 4, 2021, pertaining to the registration of an additional 2,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan;

 

 

Registration Statement on Form S-8 (No. 333‑265774), filed with the SEC on June 22, 2022, pertaining to the registration of an additional 2,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan;

 

 

Registration Statement on Form S-8 (No. 333‑272995), filed with the SEC on June 28, 2023, pertaining to the registration of an additional 1,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan; and

 

 

Registration Statement on Form S-8 (No. 333‑280444), filed with the SEC on June 24, 2024, pertaining to the registration of 6,738,902 shares of Common Stock of the Registrant, which consists of (i) 6,000,000 shares of Common Stock reserved for issuance under the Streamline Health Solutions, Inc. 2024 Omnibus Incentive Compensation Plan (the “2024 Plan”) and (ii) 738,902 shares of Common Stock available for issuance (or which may become available for issuance) under the 2013 Plan.

 

The number of shares of Common Stock registered under the Registration Statements set forth above have not been adjusted to reflect the 1-for-15 reverse stock split of the issued and outstanding shares of Common Stock effected by the Company on October 4, 2024.

 

On August 12, 2025, pursuant to the terms of the Agreement and Plan of Merger, dated May 29, 2025, by and among the Registrant, Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit (“Parent”), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Registrant (the “Merger”), with the Registrant surviving the Merger as a wholly owned subsidiary of Parent.

 

As a result of the Merger, the Registrant has terminated, as of the date hereof, all offerings of its securities pursuant to its existing registration statements under the Securities Act of 1933, as amended (the “Securities Act”), including the Registration Statements. In accordance with an undertaking made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities which remain unsold at the termination of the offering, Registrant hereby removes and withdraws from registration all securities of the Registrant registered pursuant to the Registration Statements that remain unsold as of the date hereof, and the Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such securities. 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Atlanta, State of Georgia, on August 14, 2025. No other person is required to sign these Post-Effective Amendments to the Registration Statements on Form S-8 in reliance on Rule 478 of the Securities Act

 

STREAMLINE HEALTH SOLUTIONS, INC.

 

 

By: /s/ Nick Barnes                                             

Nick Barnes

Chief Financial Officer, Treasurer and Secretary 

 

 


 

 
Streamline Health Solutions In

NASDAQ:STRM

STRM Rankings

STRM Latest News

STRM Latest SEC Filings

STRM Stock Data

23.23M
3.60M
17.45%
26.05%
0.51%
Health Information Services
Services-computer Integrated Systems Design
Link
United States
ALPHARETTA